Skip to main content
All lobbying filings

ASCENSION HEALTH ALLIANCE D/B/A ASCENSION

Lobbying for ASCENSION HEALTH ALLIANCE D/B/A ASCENSION

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $485,000.00 expenses · posted Jan 16, 2026

Official filing document

 Bills named in this filing 6
  • S 4352
    Fair and Transparent Gas Prices Act of 2026
  • HR 8702
    Secret Service Transfer Act of 2026
  • HR 2433
    Reducing Medically Unnecessary Delays in Care Act of 2025
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 247
    Health Care Affordability Act of 2025
  • S 46
    Health Care Affordability Act of 2025
 Lobbying activity 5
Health Issues

340B Program; Issues related to affordable prescription drugs; Issues related to health care workforce and staffing; Issues related to health care privacy; Issues related to telehealth authorities; Issues related to hospital price transparency; Issues related to hospital reimbursement; Issues related to nonprofit hospital practices; Issues related to hospital outpatient department payments; Issues related to hospital outpatient department payments; Medicaid Disproportionate Share Hospital payment adjustment program; Issues related to Medicare payments; Issues related to Medicare Advantage payment and prior authorization; Childrens Hospital Graduate Medical Education Program (CHGME); issues related to childrens medical care; issues related to rural health; S. 4352/H.R. 8702, Equitable Community Access to Pharmacy Services Act; issues related to Program for All-Inclusive Care for the Elderly (PACE); Issues related to mental and behavioral health; issues related to extending programs under the SUPPORT for Patients Communities Act; issues related to cybersecurity; enhanced Advanced Premium Tax Credits; H.R. 2433, the Reducing Medically Unnecessary Delays in Care Act; H.R. 1, the One Big Beautiful Bill Act

Medicare/Medicaid

Issues related to Medicare and Medicaid payments; Issues related to affordable prescription drugs; Issues related to telehealth authorities; Issues related to health care workforce and staffing; Medicaid Disproportionate Share Hospital payment adjustment program; Issues related to Medicaid coverage; issues related to Medicaid supplemental payments; issues related to provider taxes; Issues related to hospital reimbursement; 340B Program; Issues related to hospital price transparency; Issues related to Medicare payments; Issues related to Medicare Advantage payment and prior authorization; issues related to rural health reimbursement, including the Medicare Dependent Hospital and Low Volume Hospital programs; physician reimbursement rates; issues related to Program for All-Inclusive Care for the Elderly (PACE); issues related to improving coordination of care for dual eligibles; issues related to site neutral payments; issues related to prior authorization, unwarranted claim denials, and payment delays; Issues related to mental and behavioral health; issues related to extending programs under the SUPPORT for Patients Communities Act; H.R. 2433, the Reducing Medically Unnecessary Delays in Care Act, H.R. 1, the One Big Beautiful Bill Act; implementation of PL 119-21

Pharmacy

340B Program; Issues related to affordable prescription drugs; Equitable Community Access to Pharmacy Services Act; issues related to preventing and mitigating drug shortages;

Budget/Appropriations

H.R. 1, the One Big Beautiful Bill Act

Taxation/Internal Revenue Code

H.R. 247/S. 46, the Healthcare Affordability Act; extending advanced premium tax credits (APTCs); issues related to provider taxes.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem